Thursday, May 29, 2025

renal failure treated by ACE-I

Q: Which type of renal failure is treated/managed by ACE inhibitors?


Answer: Scleroderma Renal Crisis!

Scleroderma Renal Crisis is one of the few rheumatological emergencies where early diagnosis and treatment can make a big difference in outcome. A wrong diagnosis may lead to the wrong management pathway and high mortality. SRC is heralded by a hypertensive crisis associated with acute renal failure. Still, the pearl is to avoid IV Labetolol or nitroprusside and gradually decrease blood pressure with PO angiotensin-converting enzyme (ACE) inhibitors. Calcium channel blockers may help. Renal dialysis is a last resort. It has been suggested that the use of steroids is associated with the onset of scleroderma renal crisis.

#rheumatology



References:

1. Cole A, Ong VH, Denton CP. Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis. Clin Rev Allergy Immunol. 2023 Jun;64(3):378-391. doi: 10.1007/s12016-022-08945-x. Epub 2022 Jun 1. PMID: 35648373; PMCID: PMC10167155.

2. Hudson M, Ghossein C, Steen V. Scleroderma renal crisis. Presse Med. 2021 Apr;50(1):104063. doi: 10.1016/j.lpm.2021.104063. Epub 2021 Feb 3. PMID: 33548376.

No comments:

Post a Comment